Novo Nordisk, the parent company of Wegovy, told Newsweek that this study "highlights the chronic nature of obesity and suggest that ongoing treatment is necessary." Eli Lilly and Company, the parent company of Mounjaro, told Newsweek : "When treatment is stopped, weight can return, which reflects the biology of the condition rather than a lack of effort." Newsweek reached out to the Centers for Disease Control and Prevention (CDC) via email for comment
Yildirim AK, Dastan AO, Demeli Ertus M, Ensarioglu M, Karabacak K, Pehlivanoglu B
The timeline varies by medication, dose, and individual tolerance
Not all patients require or tolerate 25 mg
The new Sitesmart 12-pack is also GLP-1 products monograph recommendation on ensuring proper injection site rotation,
What can I track besides GLP-1 medication